4/11
02:03 am
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/4
06:08 pm
akba
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management [Seeking Alpha]
Low
Report
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management [Seeking Alpha]
4/3
02:04 am
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/2
04:05 pm
akba
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/1
09:31 am
akba
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
High
Report
Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?
3/28
12:01 pm
akba
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia [Yahoo! Finance]
Medium
Report
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia [Yahoo! Finance]
3/28
10:14 am
akba
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
3/28
09:31 am
akba
Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?
High
Report
Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?
3/28
09:19 am
akba
Stocks Set To Close Blowout Week, Month And Quarter At All-Time High; Gold Soars To Record [zero hedge]
High
Report
Stocks Set To Close Blowout Week, Month And Quarter At All-Time High; Gold Soars To Record [zero hedge]
3/28
08:28 am
akba
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD [Yahoo! Finance]
High
Report
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD [Yahoo! Finance]
3/28
05:42 am
akba
Biggest stock movers today: RH, AKBA, and more [Seeking Alpha]
High
Report
Biggest stock movers today: RH, AKBA, and more [Seeking Alpha]
3/27
08:46 pm
akba
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis [Yahoo! Finance]
Medium
Report
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis [Yahoo! Finance]
3/27
08:26 pm
akba
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Medium
Report
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
3/26
11:02 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
High
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/22
09:31 am
akba
Thinking about buying stock in Akebia Therapeutics, Boeing, Aquestive Therapeutics, General Electric, or Canoo?
Medium
Report
Thinking about buying stock in Akebia Therapeutics, Boeing, Aquestive Therapeutics, General Electric, or Canoo?
3/21
09:31 am
akba
Thinking about buying stock in SoundHound AI, Aquestive Therapeutics, Akebia Therapeutics, Kaival Brands, or Lufax?
Medium
Report
Thinking about buying stock in SoundHound AI, Aquestive Therapeutics, Akebia Therapeutics, Kaival Brands, or Lufax?
3/20
09:31 am
akba
Thinking about buying stock in MicroCloud Hologram, Akebia Therapeutics, Mind Medicine, Treasure Global, or Getty Images?
Medium
Report
Thinking about buying stock in MicroCloud Hologram, Akebia Therapeutics, Mind Medicine, Treasure Global, or Getty Images?
3/18
11:06 pm
akba
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/18
09:31 am
akba
Thinking about buying stock in 2Seventy Bio, Verb Technology, Exscientia, MicroCloud Hologram, or Akebia Therapeutics?
Medium
Report
Thinking about buying stock in 2Seventy Bio, Verb Technology, Exscientia, MicroCloud Hologram, or Akebia Therapeutics?
3/17
09:47 am
akba
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.33 [Yahoo! Finance]
High
Report
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.33 [Yahoo! Finance]
3/14
04:28 pm
akba
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/14
04:15 pm
akba
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
High
Report
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
3/11
05:07 pm
akba
Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/11
05:05 pm
akba
Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Low
Report
Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
3/1
04:05 pm
akba
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)